250
Views
20
CrossRef citations to date
0
Altmetric
Review

Management of achalasia

, , &
Pages 33-41 | Published online: 25 Feb 2011

References

  • ParkWVaeziMFEtiology and pathogenesis of achalasia: The current understandingAm J Gastroenterol20051001404140415929777
  • ZarateNMearinFGil-VernetJMAchalasia and Down’s syndrome: Coincidental association or something else?Am J Gastroenterol1999941674167710364043
  • WongRKMaydonovitchCLMetzSJBakerJRJrSignificant DQw1 association in achalasiaDig Dis Sci1989343493522920639
  • Ruiz-de-LeonAMendozaJSevilla-MantillaCMyenteric antiplexus antibodies and class II HLA in achalasiaDig Dis Sci200247151911837716
  • RobertsonCSMartinBAAtkinsonMVaricella-zoster virus DNA in the esophageal myenteric plexus in achalasiaGut1993342993028386130
  • VerneGNSallustioJEEakerEYAnti-myenteric neuronal antibodies in patients with achalasia. A prospective studyDig Dis Sci1997423073139052511
  • GockelIEckardtVFSchmittTJungingerTPseudoachalasia: A case series and analysis of the literatureScand J Gastroenterol20054037838516028431
  • PohDLTutuianR2007. Achalasia: An overview of diagnosis and treatmentJ Gastrointestin Liver Dis20074297303
  • SpechlerNCastellDClassification of esophageal motility abnormalitiesGut20014914515111413123
  • AggestrupSUddmanRSundlerFLack of vasoactive intestinal polypeptide nerves in esophageal achalasiaGastroenterology1983849249276832568
  • HiranoIPathophysiology of achalasia and diffuse esophageal spasmGI Motility Online200610.1038/gimo22.
  • KraichelynREFarrugiaGAchalasia: Physiology and etiopathogenesisDis Esophagus20061921322316866850
  • Faussone-PellegriniMSCortesiniCUltrastructural features and localization of the interstitial cells of Cajal in the smooth muscle coat of human esophagusJ Submicrosc Cytol1985171871973999182
  • SzurszewskiJHFarrugiaGCarbon monoxide is an endogenous hyperpolarizing factor in the gastrointestinal tractNeurogastroenterol Motil200416818515066010
  • FoxEAPhillipsRJMartinsonFABaronowskyEAPowleyTLC-Kit mutant mice have a selective loss of vagal intramuscular mechanoreceptors in the forestomachAnat Embryol2001204112611506430
  • WardSMMorrisGReeseLWangXYSandersKMInterstitial cells of Cajal mediate enteric inhibitory neurotransmission in the lower esophageal and pyloric sphinctersGastroenterology19981153143299679037
  • ZarateNWangXYTougasGIntramuscular interstitial cells of Cajal associated with mast cells survive nitrergic nerves in achalasiaNeurogastroenterol Motil20061855656816771771
  • HuizingaJDZarateNFarrugiaGPhysiology, injury, and recovery of interstitial cells of Cajal: Basic and clinical scienceGastroenterology20091371548155619778538
  • BortolottiMLaboGClinical and manometric effects of nifedipine in patients with esophageal achalasiaGastroenterology19818039447450409
  • TriadafilopoulosGAaronsonMSackelSBurakoffRMedical treatment of esophageal achalasia. Double-blind crossover study with oral nifedipine, verapamil and placeboDig Dis Sci1991362602671995258
  • TraubeMDubovikSLangeRCMcCallumRWThe role of nifedipine therapy in achalasia: Results of a randomized, double blind, placebo-controlled studyAm J Gastroenterol198984125912622679048
  • BortolottiMMedical therapy of achalasia: A benefit reserved for fewDigestion19996011169892793
  • BortolottiMCocciaGBrunelliFIsosorbide dinitrate or nifedipine: Which is preferable in the medical therapy of achalasia?Ital J Gastroenterol1994263793827703511
  • WenZHGardenerEWangYPNitrates for achalasiaCochrane Database Syst Rev2004CD00229914973987
  • BortolottiMMariCLopilatoCPorrazzoGMiglioliMEffects of sildenafil on esophageal motility of patients with idiopathic achalasiaGastroenterology200011825325710648452
  • PasrichaPJRavichWJHendrixTRSostreSJonesBKallooANIntrasphincteric botulinum toxin for the treatment of achalasiaN Engl J Med19953327747787862180
  • AnneseVBassottiGNon-surgical treatment of esophageal achalasiaWorld J Gastroenterol2006125763576617007039
  • AnneseVBassottiGCocciaGMulticenter randomised study of intrasphincteric botulinum toxin in patients with esophageal achalasia. GISMAD Achalasia Study GroupGut20004659760010764700
  • PasrichaPJRaiRRavichWJHendrixTRKallooANBotulinum toxin for achalasia: Long-term outcome and predictors of responseGastroenterology1996110141014158613045
  • PehlivanovNPasrichaPJAchalasia: Botox, dilatation or laparoscopic surgery in 2006Neurogastroenterol Motil20061879980416918758
  • DugheraLBattagliaEMaggioDBotulinum toxin treatment of esophageal achalasia in the old old and oldest old: A 1-year follow-up studyDrugs Aging20052277978316156681
  • WillisTPharmaceutice Rationalis Sive Diatriba do Medicamentorum Operationibus in Humano CorporeLondonHagea Comitis1674
  • MikaeliJBishehsariFMontazeriGYaghoobiMMalekzadehRPneumatic balloon dilatation in achalasia: A prospective comparison of safety and efficacy with different balloon diametersAliment Pharmacol Ther20042043143615298637
  • KadakiaSCWongRKGraded pneumatic dilation using Rigiflex achalasia dilators in patients with primary esophageal achalasiaAm J Gastroenterol19938834388420271
  • WongRKPneumatic dilation for achalasiaAm J Gastroenterol20049957858015089884
  • ZerbibFThetiotVRichyFBenajahDAMessageLLamouliatteHRepeated pneumatic dilations as long-term maintenance therapy for esophageal achalasiaAm J Gastroenterol200610169269716635216
  • LevineMLDorfBSMoskowitzGBankSPneumatic dilatation in achalasia under endoscopic guidance: Correlation pre- and postdilatation by radionuclide scintiscanAm J Gastroenterol1987823113143565334
  • American Society for Gastrointestinal EndoscopyEsophageal dilationGastrointest Endosc1998487027049852480
  • MoawadFJWongRKModern management of achalasiaCurr Opin Gastroenterol20102638438820502326
  • NovaisPALemmeEM24-h pH monitoring patterns and clinical response after achalasia treatment with pneumatic dilation or laparoscopic Heller myotomyAliment Pharmacol Ther2010321257126520955445
  • LeydenJEMossACMacMathunaPEndoscopic pneumatic dilation versus botulinum toxin injection in the management of primary achalasiaCochrane Database Syst Rev2006CD00504617054234
  • WangLLiYMLiLMeta-analysis of randomized and controlled treatment trials for achalasiaDig Dis Sci2009542303230119107596
  • PattiMGFisichellaPMPerrettaSImpact of minimally invasive surgery on the treatment of esophageal achalasia: A decade of changeJ Am Coll Surg200319669870312742198
  • IshaqSTreatment of achalasia: The role of laparoscopic cardiomyotomy needs to be emphasizedAm J Gastroenterol2004992278227915555011
  • MineoTCAmbrogiVLong-term results and quality of life after surgery for esophageal achalasia: One surgeon’s experienceEur J Cardiothorac Surg2004251089109615145014
  • FinleyRJCliftonJCStewartKCGrahamAJWorsleyDFLaparoscopic Heller myotomy improves esophageal emptying and the symptoms of achalasiaArch Surg200113689289611485524
  • LitleVRLaparoscopic Heller myotomy for achalasia: A review of the controversiesAnn Thorac Surg200885Suppl 74346
  • CsendesABraghettoIHenriquezALate results of a prospective randomised study comparing forceful dilatation and oesophagomyotomy in patients with achalasiaGut1989302993042651226
  • BoeckxstaensGEAnneseVBruley des VarannesSThe European achalasia trial: A randomized multi-centre trial comparing endoscopic pneumodilation and laparoscopic Heller myotomy as primary treatment of idiopathic achalasiaGut201059Suppl IIIA25
  • VelaMFRichterJEKhandwalaFThe long-term efficacy of pneumatic dilatation and Heller myotomy for the treatment of achalasiaClin Gastroenterol Hepatol2006458058716630776
  • DuranceauALibermanMMartinJFerraroPEnd-stage achalasiaDis EsophagusDecemeber172010 [Epub ahead of print].
  • HsuHSWangCYHsiehCCHuangMHShort-segment colon interposition for end-stage achalasiaAnn Thorac Surg2003761706171014602317
  • GockelITimmSSgourakisGGMusholtTJRinkADLangHAchalasia – if surgical treatment fails: Analysis of remedial surgeryJ Gastrointest Surg201014Suppl 1S46S5719856034
  • FoleyNTeasellRSalterKKrugerEMartinoRDysphagia treatment post stroke: A systematic review of randomised controlled trialsAge Ageing20083725826418456790
  • BowerMRMartinRC2ndNutritional management during neoadjuvant therapy for esophageal cancerJ Surg Oncol2009100828719373870
  • PardoeEMDevelopment of a multistage diet for dysphagiaJ Am Diet Assoc1993935685718315168
  • GivenMFHansonJJLeeMJInterventional radiology techniques for provision of enteral feedingCardiovasc Intervent Radiol20052869270316184329
  • ZhaoJGLiYDChengYSLong-term safety and outcome of a temporary self-expanding metallic stent for achalasia: A prospective study with a 13-year single-center experienceEur Radiol2009191973198019296113
  • PasrichaPJHawariRAhmedISubmucosal endoscopic esophageal myotomy: A novel experimental approach for the treatment of achalasiaEndoscopy20073976176417703382
  • InoueHMinamiHKobayashiYPeroral endoscopic myotomy (POEM) for esophageal achalasiaEndoscopy20094226527120354937
  • MinamiHInoueHHosoyaTPer-oral endoscopic myotomy: POEM – 35 cases clinical experiences – noble endoscopic treatment against esophageal achalasiaGut201059Suppl IIIA2
  • De GiorgioRGuerriniSBarbaraGInflammatory neuropathies of the enteric nervous systemGastroenterology20041261872187315188182
  • MicciMALearishRDLiHNeural stem cells express RET, produce nitric oxide, and survive transplantation in the gastrointestinal tractGastroenterology200112175776611606488
  • UrbachDRHansenPDKhajancheeYSA decision analysis of the optimal initial approach to achalasia: Laparoscopic Heller myotomy with partial fundoplication, thoracoscopic Heller myotomy, pneumatic dilatation, or botulinum toxin injectionJ Gastrointest Surg2001519220511331483
  • O’ConnorJBSingerMEImperialeTFVaeziMFRichterJEThe cost-effectiveness of treatment strategies for achalasiaDig Dis Sci2002471516152512141811
  • PanaccioneRGregorJCReynoldsRPPreiksaitisHGIntrasphincteric botulinum toxin vs pneumatic dilatation for achalasia: A cost minimization analysisGastrointest Endosc19995049249810502169
  • ZayatENSchusterMMNitric oxide – a major player in esophageal motilityAm J Gastroenterol2000951584158510894602